BMRA (STOCKS)
BIOMERICA INC
$1.600000
+0.000000 (+0.00%)
Prev close: $1.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Zackary S. Irani
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5.14M
- Employees
- 54
- P/E (TTM)
- -1.05
- P/B (TTM)
- 1.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2026 (Q3)
|
$-0.44 | $0.00 | +0.0000 | +0.00% |
|
Jun 2024 (Q2)
|
$-0.09 | $0.00 | +0.0000 | +0.00% |
|
Jun 2023 (Q2)
|
$-0.12 | $0.00 | +0.0000 | +0.00% |
|
Dec 2021 (Q2)
|
$-0.72 | $-0.65 | -0.0672 | -10.29% |
Financial Statements
| Revenues | $4.46M |
| Benefits Costs and Expenses | $8.47M |
| Cost Of Revenue | $4.21M |
| Costs And Expenses | $8.47M |
| Gross Profit | $250.00K |
| Nonoperating Income/Loss | $1.25M |
| Operating Expenses | $5.52M |
| Selling, General, and Administrative Expenses | $4.64M |
| Depreciation and Amortization | $84.00K |
| Research and Development | $874.00K |
| Operating Income/Loss | -$5.27M |
| Income/Loss From Continuing Operations After Tax | -$4.02M |
| Income/Loss From Continuing Operations Before Tax | -$4.02M |
| Interest And Dividend Income, Operating | $1.25M |
| Net Income/Loss | -$4.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$4.03M |
| Net Income/Loss Available To Common Stockholders, Basic | -$4.03M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.49 |
| Diluted Earnings Per Share | -$2.49 |
| Basic Average Shares | 8,413,223 |
| Diluted Average Shares | 8,413,223 |
| Assets | $6.03M |
| Current Assets | $5.19M |
| Inventory | $1.52M |
| Other Current Assets | $3.67M |
| Noncurrent Assets | $843.00K |
| Fixed Assets | $105.00K |
| Intangible Assets | $219.00K |
| Other Non-current Assets | $519.00K |
| Liabilities | $1.60M |
| Current Liabilities | $1.60M |
| Wages | $545.00K |
| Other Current Liabilities | $1.05M |
| Noncurrent Liabilities | $0.00 |
| Equity | $4.44M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.44M |
| Liabilities And Equity | $6.03M |
| Net Cash Flow From Operating Activities | -$2.97M |
| Net Cash Flow From Operating Activities, Continuing | -$2.97M |
| Net Cash Flow From Investing Activities | -$147.00K |
| Net Cash Flow From Investing Activities, Continuing | -$1.94M |
| Net Cash Flow From Financing Activities | $3.13M |
| Net Cash Flow From Financing Activities, Continuing | $3.13M |
| Net Cash Flow | -$1.77M |
| Net Cash Flow, Continuing | -$1.77M |
| Comprehensive Income/Loss | -$4.02M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$4.02M |
| Other Comprehensive Income/Loss | -$4.02M |